Fundraising FoxNextwavepharma
AcquiredNew Jersey, US · 3 known investors
Find your way into Nextwavepharma
Sign up to see every warm intro you have to Nextwavepharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nextwavepharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nextwave Pharma markets Quillivant XR, a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 and older. The product is a liquid medication taken orally and is a federally controlled substance.
Investors · 3
Frequently asked questions
- What does Nextwavepharma do?
- Nextwave Pharma markets Quillivant XR, a prescription central nervous system stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 and older. The product is a liquid medication taken orally and is a federally controlled substance.
- Who are Nextwavepharma's investors?
- Nextwavepharma's investors include Bay City Capital, F-Prime Capital, Sofinnova Ventures.
- Where is Nextwavepharma headquartered?
- Nextwavepharma is headquartered in New Jersey, US.